Position in BVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,569,056
+$2,441,557 QoQ
Shares Held
907,739
+35.3% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#12
of 155 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in BVS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Hillsdale Investment Management Inc. holds $19,365,255 across 7 Medical Devices names. BVS ranks #1 (44.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BVS |
Bioventus Inc.
This page
|
907,739 | $8,569,056 | |
| 2 | INFU |
InfuSystem Holdings, Inc
|
424,473 | $4,096,164 | |
| 3 | VMD |
Viemed Healthcare, Inc.
|
225,109 | $2,566,242 | |
| 4 | NVCR |
NovoCure Ltd
|
141,900 | $2,149,785 | |
| 5 | ABT |
Abbott Laboratories
|
9,100 | $825,734 | |
| 6 | APYX |
Apyx Medical Corp
|
182,600 | $819,874 | |
| 7 | ELMD |
Electromed, Inc.
|
8,000 | $338,400 |
All Filings in BVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,569,056 | 907,739 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,127,499 | 671,139 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,008,122 | 269,909 | Shares | Sole | 2026-02-10 | |
| 2025-03-31 | $251,094 | 27,442 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $294,966 | 28,092 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $372,743 | 31,192 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $227,941 | 39,642 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $180,658 | 34,742 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $145,146 | 27,542 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||